Ubiquitination and dimerization of complement receptor type 2 on sheep B cells

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Complement receptor type 2 (CR2) is a key immune regulator binding C3d and other ligands.
• CR2's role in immunity involves regulating B lymphocyte function.
• Understanding CR2 structure and expression is crucial for immune system research.

Purpose of the Study:

• To investigate the distinct isoforms of CR2 expressed on sheep B lymphocytes.
• To characterize the structural and functional properties of these CR2 isoforms.
• To explore the potential role of ubiquitination in CR2 regulation.

Main Methods:

• Surface expression analysis of CR2 isoforms on sheep B cells.
• Structural characterization of CR2 isoforms, including ubiquitination.
• Analysis of sheep CR2 primary sequence for structural motifs.
• In vivo studies to assess CR2 function during B cell development.

Main Results:

• Two distinct CR2 isoforms, CR2no (150 kDa) and CR2ub (190 kDa), are expressed on sheep B cells.
• CR2ub is a novel isoform modified by ubiquitin attachment to its cytoplasmic domain.
• Both isoforms exist as noncovalently associated dimers with differing surface topography.
• Sheep CR2 sequence contains a dimerization motif and potential ubiquitination sites.

Conclusions:

• Sheep B cells express unique CR2 isoforms, including a novel ubiquitinated form.
• Ubiquitination of CR2 may modulate its higher-order structure and/or expression.
• These findings provide insights into CR2 regulation during B cell development.
• The conserved nature of sheep ubiquitin and C3d suggests functional relevance.